| Date Filed | Type | Description |
| 06/12/2023 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 02/10/2023 |
SC 13G/A
| Satter Muneer A reports a 8.2% stake in Akebia Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| Satter Muneer A reports a 6.7% stake in Aadi Bioscience, Inc. |
| 12/19/2022 |
SC 13G
| Satter Muneer A reports a 7.5% stake in Akebia Therapeutics, Inc. |
| 10/04/2022 |
SC 13G
| Satter Muneer A reports a 5.3% stake in Aadi Bioscience, Inc. |
| 07/18/2022 |
SC 13D
| Satter Muneer A reports a 10.4% stake in Annexon, Inc. |
| 07/11/2022 |
4
| Satter Muneer A (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Bought 2,453,988 shares
@ $3.84, valued at
$9.4M
Bought 613,497 warrants
@ $5.8069, valued at
$3.6M
|
|
| 06/13/2022 |
4
| Satter Muneer A (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $3.84, valued at
$92.2k
|
|
| 02/10/2022 |
SC 13G/A
| Satter Muneer A reports a 4.7% stake in Assembly Biosciences, Inc. |
| 11/12/2021 |
SC 13D/A
| Satter Muneer A reports a 1.8% stake in Aadi Bioscience, Inc. |
| 08/12/2021 |
3
| Satter Muneer A (Director) has filed a Form 3 on AxonPrime Infrastructure Acquisition Corp |
| 06/04/2021 |
4
| Satter Muneer A (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 10,000 options to buy
@ $21.03, valued at
$210.3k
|
|
| 02/12/2021 |
SC 13G/A
| Satter Muneer A reports a 6.7% stake in Assembly Biosciences, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G
| Satter Muneer A reports a 5.1% stake in Annexon, Inc. |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/28/2020 |
4
| Satter Muneer A (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Converted 1,754,978 shares
@ $0
Bought 200,000 shares
@ $17, valued at
$3.4M
Converted 3,095,238 preferred shares
@ $0
Converted 4,016,573 preferred shares
@ $0
Converted 5,537,036 preferred shares
@ $0
Converted 2,812,543 preferred shares
@ $0 |
|
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2020 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Bought 3,700,000 shares
@ $1.1, valued at
$4.1M
|
|
| 06/09/2020 |
SC 13D/A
| Satter Muneer A reports a 19.9% stake in Aileron Therapeutics, Inc. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/19/2019 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 21,400 options to buy
@ $0.96, valued at
$20.5k
|
|
| 04/11/2019 |
SC 13D/A
| Satter Muneer A reports a 19.9% stake in Aileron Therapeutics, Inc. |
| 04/10/2019 |
SC 13D
| Satter Muneer A reports a 25.1% stake in Aileron Therapeutics, Inc. |
| 04/03/2019 |
3
| Satter Muneer A (10% Owner) has filed a Form 3 on AILERON THERAPEUTICS INC |
| 02/13/2019 |
SC 13G/A
| Satter Muneer A reports a 7% stake in Albireo Pharma, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/11/2019 |
SC 13D/A
| Satter Muneer A reports a 2.6% stake in Akebia Therapeutics, Inc. |
| 01/11/2019 |
SC 13D/A
| Satter Muneer A reports a 13.9% stake in Aerpio Pharmaceuticals, Inc. |
| 01/10/2019 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $2.1986, valued at
$44k
Bought 20,000 shares
@ $2.3938, valued at
$47.9k
Bought 23,818 shares
@ $2.4537, valued at
$58.4k
|
|
| 01/07/2019 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $2.0754, valued at
$41.5k
Bought 20,000 shares
@ $2.1198, valued at
$42.4k
Bought 20,000 shares
@ $2.1779, valued at
$43.6k
|
|
| 01/02/2019 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $1.7186, valued at
$34.4k
Bought 20,000 shares
@ $1.745, valued at
$34.9k
Bought 20,000 shares
@ $1.9419, valued at
$38.8k
|
|
|